Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Stage II (Resectable)”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Testing effectiveness (Phase 2)Study completedNCT00043108
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04846634
What this trial is testing

Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)

Who this might be right for
Resectable Locally Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06779539
What this trial is testing

Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
West China Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT03968419
What this trial is testing

This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 88
Testing effectiveness (Phase 2)Study completedNCT00226577
What this trial is testing

Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07229339
What this trial is testing

Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Squamous Non-Small Cell Carcinoma
Jonsson Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT02927301
What this trial is testing

Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 181
Large-scale testing (Phase 3)Study completedNCT00003159
What this trial is testing

Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Medical Research Council 600
Testing effectiveness (Phase 2)UnknownNCT01091376
What this trial is testing

Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 75
Testing effectiveness (Phase 2)Study completedNCT00198432
What this trial is testing

Chemoradiotherapy of NSCLC Stage IIIB

Who this might be right for
NSCLC Stage IIIBConcomitant Radiochemotherapy
Intergroupe Francophone de Cancerologie Thoracique 130
Large-scale testing (Phase 3)Looking for participantsNCT06623422
What this trial is testing

Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 680
Testing effectiveness (Phase 2)Active Not RecruitingNCT05925530
What this trial is testing

Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 142
Large-scale testing (Phase 3)Looking for participantsNCT06284317
What this trial is testing

Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
ETOP IBCSG Partners Foundation 290
Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Testing effectiveness (Phase 2)Study completedNCT00025389
What this trial is testing

Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Chicago 8
Testing effectiveness (Phase 2)Looking for participantsNCT06659042
What this trial is testing

Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
Shanghai Chest Hospital 32
Testing effectiveness (Phase 2)Ended earlyNCT04560686
What this trial is testing

Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+8 more
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT06951464
What this trial is testing

BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sichuan University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05962021
What this trial is testing

Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation

Who this might be right for
Non Squamous Non Small Cell Lung CancerEGFR Positive Non-small Cell Lung Cancer
Peking University People's Hospital 126
Load More Results